The Skinhouse Wrinkle Supremecream
Panax Ginseng Extract
Noksibcho Cosmetic Co., Ltd.
Human Otc Drug
NDC 73590-0005The Skinhouse Wrinkle Supremecream also known as Panax Ginseng Extract is a human otc drug labeled by 'Noksibcho Cosmetic Co., Ltd.'. National Drug Code (NDC) number for The Skinhouse Wrinkle Supremecream is 73590-0005. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in The Skinhouse Wrinkle Supremecream drug includes Asian Ginseng - .5 g/100mL . The currest status of The Skinhouse Wrinkle Supremecream drug is Active.
Drug Information:
| Drug NDC: | 73590-0005 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | The Skinhouse Wrinkle Supremecream |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Panax Ginseng Extract |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Noksibcho Cosmetic Co., Ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ASIAN GINSENG - .5 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 22 Jan, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | NOKSIBCHO cosmetic Co., Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | CUQ3A77YXI
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73590-0005-1 | 50 mL in 1 BOTTLE (73590-0005-1) | 22 Jan, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
All skin types, especially for those who wants to improve and prevent wrinkles the ginseng extract and 9 types of mushroom extracts will fill up skin with nutrition. you will feel the elasticity once you apply cream onto your skin. it contains the mushroom extract which has antioxidant ingredients for anti-aging and anti-wrinkle. and it also contains ginseng ingredients which is full of nutrition. it will help skin to relieve stress from external environment and help skin to look vital, radiant and elastic. must have cream for recovery of skin fatigue and skin care
Product Elements:
The skinhouse wrinkle supremecream panax ginseng extract water butylene glycol asian ginseng asian ginseng
Indications and Usage:
After cleansing, use toner to smooth the skin texture. apply the serum or the emulsion to the face, and let it be absorbed deeply into skin. apply a small amount of the cream to the face, and spread it along the skin texture
Warnings:
For external use only when using this product â if the following symptoms occurs after use, stop use and consult with a skin specialist red specks, swelling, itching â donât use on the part where there is injury, eczema, or dermatitis keep out of reach of children â if swallowed, get medical help or contact a person control center immediately
Dosage and Administration:
For external use only
Package Label Principal Display Panel:
Label